fluorodeoxyglucose f18 has been researched along with Weight Gain in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cho, JY; Choi, BJ; Jeon, YH; Kang, HJ; Kim, DW; Lee, IK; Min, BK | 1 |
Barres, B; Chanchou, M; Coudert, B; Durando, X; Gadéa, E; Ginzac, A; Merlin, C; Molnar, I; Thivat, E | 1 |
Arguin, G; Beaudoin, JF; Bourzac, JF; Gendron, FP; Lecomte, R; Molle, CM; Paquette, M; Placet, M; Plourde, M; Rousseau, JA | 1 |
Divoux, JL; Genissel, M; Henry, C; Malbert, CH | 1 |
Choi, SJ; Jang, M; Jeon, YK; Kim, BH; Kim, EH; Kim, IJ; Kim, JM; Kim, K; Kim, M; Kim, SJ; Kim, SS; Pak, K | 1 |
Chen, K; Krakoff, J; Lutrin, C; Piaggi, P; Reiman, EM; Schlögl, M; Thearle, MS; Thiyyagura, P | 1 |
Boirie, Y; Chadeyras, JB; Coudert, B; Durando, X; Gadea, E; Kwiatkowski, F; Merlin, C; Morio, B; Paulon, R; Thivat, E | 1 |
Byrne, BJ; Chen, PW; Cheng, CH; Chien, YH; Hu, MK; Hwu, WL; Lee, NC; Liu, WS; Muramatsu, S; Tzen, KY; Wang, WH | 1 |
De Maertelaer, V; Delvenne, V; Goldman, S; Lotstra, F; Luxen, A; Simon, Y | 1 |
Braun, K; Poeggel, G | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and Weight Gain
Article | Year |
---|---|
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients.
Topics: Adipose Tissue, Brown; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Trastuzumab; Treatment Outcome; Weight Gain | 2020 |
Overfeeding over 24 hours does not activate brown adipose tissue in humans.
Topics: Adipose Tissue, Brown; Adiposity; Adult; Body Mass Index; Cohort Studies; Cold Temperature; Fasting; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperphagia; Male; Overweight; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Weight Gain | 2013 |
8 other study(ies) available for fluorodeoxyglucose f18 and Weight Gain
Article | Year |
---|---|
Phenylbutyrate Ameliorates High-Fat Diet-Induced Obesity via Brown Adipose Tissue Activation.
Topics: Adipocytes; Adipose Tissue, Brown; Animals; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Eating; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Insulin Resistance; Male; Mice, Inbred C57BL; Obesity; Phenylbutyrates; Positron Emission Tomography Computed Tomography; Weight Gain | 2019 |
The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.
Topics: Absorption, Physiological; Animals; Biological Transport; Cholesterol; Down-Regulation; Dyslipidemias; Enterocytes; Fatty Liver; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 2; Hyperglycemia; Insulin; Insulin Resistance; Intestines; Jejunum; Lipid Metabolism; Male; Mice; Receptors, Purinergic P2X7; Tissue Distribution; Triglycerides; Weight Gain | 2017 |
Chronic abdominal vagus stimulation increased brain metabolic connectivity, reduced striatal dopamine transporter and increased mid-brain serotonin transporter in obese miniature pigs.
Topics: Animals; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Glucose; Mesencephalon; Neostriatum; Obesity; Positron-Emission Tomography; Serotonin Plasma Membrane Transport Proteins; Swine; Swine, Miniature; Vagus Nerve Stimulation; Weight Gain | 2019 |
Cerebral glucose metabolism differs according to future weight change.
Topics: Body-Weight Trajectory; Brain; Feeding Behavior; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Weight Gain | 2020 |
Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.
Topics: Adipose Tissue, Brown; Adult; Antibodies, Monoclonal, Humanized; Body Mass Index; Breast Neoplasms; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pilot Projects; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Trastuzumab; Weight Gain | 2014 |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Blood Pressure; Brain; Dependovirus; Disease Models, Animal; Dopamine; Enzyme Activation; Fluorodeoxyglucose F18; Gene Expression; Genetic Therapy; Genetic Vectors; Heart Rate; Immunohistochemistry; Mice; Mice, Transgenic; Motor Activity; Neurons; Neurotransmitter Agents; Organ Specificity; Positron-Emission Tomography; Transduction, Genetic; Weight Gain | 2015 |
Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain.
Topics: Adolescent; Adult; Anorexia Nervosa; Blood Glucose; Brain; Brain Mapping; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Parietal Lobe; Synaptic Transmission; Tomography, Emission-Computed; Weight Gain | 1996 |
Early auditory filial learning in degus (Octodon degus): behavioral and autoradiographic studies.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Animals, Suckling; Association Learning; Auditory Pathways; Autoradiography; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Linear Models; Maternal Behavior; Prefrontal Cortex; Reinforcement, Psychology; Rodentia; Vocalization, Animal; Weight Gain | 1996 |